A One-Stop Investing Solution

Looking for a balanced fund with consistent performance? Consider Oakmark Equity & Income.

As a do-it-yourself investor, you can pick what you perceive to be the best stock funds and the top bond funds, then set up your portfolio, rebalance it, and alter your allocations between stocks and bonds in a dynamic environment. That requires quite a lot of time, multiple decisions and considerable confidence in your own judgment.

We're guessing that the carnage in the markets and extreme levels of volatility have shattered the confidence of many folks in designing and managing their fund portfolios. You probably don't have the time anyway. With that in mind, we suggest you consider a one-stop solution in Oakmark Equity & Income (symbol OAKBX), a balanced fund with an outstanding long-term record.

Oakmark, which is co-managed by Clyde McGregor and Ed Studzinski, was launched in November 1995. From then through March 6, it returned an annualized 10%, an average of seven percentage points per year better than Morningstar's benchmark of balanced funds and seven points more than Standard & Poor's 500-stock index. Over the past ten miserable years, the fund gained 8% a year, while a basket of balanced funds returned a shade above 0% on average.

Subscribe to Kiplinger’s Personal Finance

Be a smarter, better informed investor.

Save up to 74%
https://cdn.mos.cms.futurecdn.net/hwgJ7osrMtUWhk5koeVme7-200-80.png

Sign up for Kiplinger’s Free E-Newsletters

Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.

Profit and prosper with the best of expert advice - straight to your e-mail.

Sign up

And Oakmark Equity & Income has been remarkably consistent. In its 13 full years of operation, it has landed in the top 20% of balanced funds nine times and has never been in the bottom 40% of its peer group. In 2008, the fund lost 16%, compared with the S&P 500's decline of 37%.

McGregor and Studzinski are disciplined bargain hunters who constantly compare values among stocks, among bonds, and between stocks and bonds (for this reason, Oakmark invests in companies of all sizes). Currently, for example, the portfolio has a relatively low weighting in stocks -- 52% -- but that allocation has reached as high as 66%.

In this dreadful economy, McGregor says, he's focusing on businesses with Gibraltar-like balance sheets that sell products and services with a "reason to exist in any environment." He holds a number of low-cost energy producers, such as XTO Energy (XTO) and EnCana (ECA); several makers of consumer necessities, such as Diageo (DEO), Nestlé (NSRGY.PK) and ConAgra Foods (CAG); and a bunch of health-care outfits, including Covidien (COV), Medtronic (MDT) and Laboratory Corp. of America (LH).

McGregor says he's constructed a stock portfolio of "shorter duration" than normal. By this fixed-income parlance, he means that he's reducing the portfolio's risk by leaning toward income-producing stocks that pay out cash now. So the average yield in his stock portfolio is higher than normal, and he's happy to hold stocks, such as Avon Products (AVP) and Nestlé, with a record of raising their dividends. The managers typically replace about 65% of fund's stock portfolio holdings yearly.

Oakmark Equity & Income carries annual expenses of 0.81%. With two sensible and sober managers at the helm, it makes a solid core holding for a tax-deferred portfolio.

Contributing Writer, Kiplinger's Personal Finance

Andrew Tanzer is an editorial consultant and investment writer. After working as a journalist for 25 years at magazines that included Forbes and Kiplinger’s Personal Finance, he served as a senior research analyst and investment writer at a leading New York-based financial advisor. Andrew currently writes for several large hedge and mutual funds, private wealth advisors, and a major bank. He earned a BA in East Asian Studies from Wesleyan University, an MS in Journalism from the Columbia Graduate School of Journalism, and holds both CFA and CFP® designations.